A Randomized Phase II Study of Gemcitabine and Carboplatin with or Without Cediranib As First-Line Therapy in Advanced Non-Small-cell Lung Cancer: North Central Cancer Treatment Group Study N0528.
Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer（2013）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined